REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,893,504 | -17.7% | 42,400 | -28.1% | 0.01% | -21.4% |
Q2 2023 | $42,393,860 | +8.6% | 59,000 | +24.2% | 0.01% | -12.5% |
Q1 2023 | $39,029,325 | -26.0% | 47,500 | -35.0% | 0.02% | -33.3% |
Q4 2022 | $52,740,919 | +7.2% | 73,100 | +2.4% | 0.02% | +9.1% |
Q3 2022 | $49,185,000 | -17.1% | 71,400 | -28.9% | 0.02% | -12.0% |
Q2 2022 | $59,349,000 | – | 100,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Garda Capital Partners LP | 3,500 | $2,880,360 | 0.13% |
GROUP ONE TRADING, L.P. | 31,900 | $26,252,424 | 0.09% |
SIMPLEX TRADING, LLC | 33,500 | $27,569 | 0.02% |
IMC-Chicago, LLC | 26,500 | $21,808,440 | 0.02% |
Allianz Asset Management GmbH | 12,400 | $10,204,704 | 0.02% |
SG Americas Securities, LLC | 16,700 | $1,142 | 0.01% |
JANE STREET GROUP, LLC | 42,400 | $34,893,504 | 0.01% |
JPMORGAN CHASE & CO | 32,900 | $27,075,384 | 0.00% |
Focused Wealth Management, Inc | 400 | $12,441 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |